A detailed history of Hrt Financial LP transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Hrt Financial LP holds 46,497 shares of HCWB stock, worth $19,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,497
Previous 66,659 30.25%
Holding current value
$19,063
Previous $43,000 41.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.42 - $0.7 $8,468 - $14,113
-20,162 Reduced 30.25%
46,497 $25,000
Q2 2024

Aug 12, 2024

SELL
$0.64 - $1.68 $4,130 - $10,842
-6,454 Reduced 8.83%
66,659 $43,000
Q1 2024

May 13, 2024

BUY
$1.1 - $1.77 $80,424 - $129,410
73,113 New
73,113 $127,000

Others Institutions Holding HCWB

About HCW Biologics Inc.


  • Ticker HCWB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,833,100
  • Market Cap $14.7M
  • Description
  • HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...
More about HCWB
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.